{"log_id": 5725998992002780332, "direction": 0, "words_result_num": 39, "words_result": [{"probability": {"variance": 0.002037, "average": 0.987106, "min": 0.674446}, "location": {"width": 850, "top": 148, "height": 27, "left": 153}, "words": "2C9、2C19、2D6或3A4,它也不会诱导CYP1A2、2B6、2C9、2C19或3A4。因此,本品"}, {"probability": {"variance": 9e-06, "average": 0.998119, "min": 0.987677}, "location": {"width": 609, "top": 183, "height": 28, "left": 155}, "words": "与通过这些CYP酶代谢的药物之间不可能有药代动力学相互作用"}, {"probability": {"variance": 0.00043, "average": 0.990478, "min": 0.922735}, "location": {"width": 261, "top": 221, "height": 25, "left": 195}, "words": "其它药物对非布司他的影响"}, {"probability": {"variance": 3.7e-05, "average": 0.996403, "min": 0.970777}, "location": {"width": 805, "top": 256, "height": 29, "left": 195}, "words": "非布司他通过多种代谢酶以结合和氧化两种方式代谢。每个酶亚型的相关作用还不清"}, {"probability": {"variance": 1.6e-05, "average": 0.99739, "min": 0.983365}, "location": {"width": 668, "top": 294, "height": 29, "left": 152}, "words": "楚。本品和抑制或诱导某一特定酶亚型的药物之间一般不会有相互作用"}, {"probability": {"variance": 5e-06, "average": 0.998387, "min": 0.992348}, "location": {"width": 215, "top": 332, "height": 28, "left": 197}, "words": "体内药物相互作用研究"}, {"probability": {"variance": 0.00133, "average": 0.987665, "min": 0.794294}, "location": {"width": 808, "top": 369, "height": 29, "left": 194}, "words": "茶碱:本品与茶碱同时服用时无需调整给药剂量。本品(80mg每日一次)与茶碱同服将"}, {"probability": {"variance": 0.000381, "average": 0.990725, "min": 0.925904}, "location": {"width": 850, "top": 407, "height": 28, "left": 153}, "words": "导致茶碱的Cmax和AUC分别增大6%和6.5%。茶碱的这两个参数变化被认为是无统计学意"}, {"probability": {"variance": 0.002326, "average": 0.98925, "min": 0.692861}, "location": {"width": 849, "top": 444, "height": 29, "left": 153}, "words": "义或不显著。但是,试验表明,本品对黄嘌呤氧化酶的抑制作用导致经尿排泄的1-甲基黄"}, {"probability": {"variance": 0.003589, "average": 0.982008, "min": 0.65118}, "location": {"width": 850, "top": 482, "height": 27, "left": 152}, "words": "嘌呤(茶碱的一种主要代谢物)含量增大约400倍。关于人体长期暴露于1-甲基黄嘌呤的安全"}, {"probability": {"variance": 0.003609, "average": 0.988845, "min": 0.613951}, "location": {"width": 850, "top": 518, "height": 29, "left": 151}, "words": "性,目前未开展相关试验研究。在决定同服本品与茶碱时,应考虑到1-甲基黄嘌呤的体内"}, {"probability": {"variance": 3e-06, "average": 0.998341, "min": 0.996752}, "location": {"width": 43, "top": 557, "height": 24, "left": 152}, "words": "蓄积"}, {"probability": {"variance": 0.000217, "average": 0.993562, "min": 0.920147}, "location": {"width": 810, "top": 592, "height": 29, "left": 192}, "words": "秋水仙素;本品和秋水仙素联合给药时,二者都无需进行剂量调整。本品(40mg,每"}, {"probability": {"variance": 0.007607, "average": 0.9605, "min": 0.647356}, "location": {"width": 850, "top": 629, "height": 27, "left": 153}, "words": "日一次)与秋水仙素(0.6mg,每日两次)联合给药;导致非布司他Cmax和AUC24分别增加12%"}, {"probability": {"variance": 0.000949, "average": 0.986834, "min": 0.847735}, "location": {"width": 848, "top": 666, "height": 27, "left": 151}, "words": "和7%。此外,秋水仙素(0.6mg,每日两次)与本品(每日120mg)联合给药,导致上午和下午"}, {"probability": {"variance": 0.00208, "average": 0.978584, "min": 0.772279}, "location": {"width": 627, "top": 701, "height": 27, "left": 150}, "words": "给药后Cmax或AUC出现小于11%的变化。这些变化不具临床意义,"}, {"probability": {"variance": 0.002606, "average": 0.98428, "min": 0.678877}, "location": {"width": 803, "top": 738, "height": 29, "left": 192}, "words": "萘普生:本品和萘普生联合给药,二者都无需进行剂量调整。本品(80mg,每日一次"}, {"probability": {"variance": 0.001499, "average": 0.980192, "min": 0.823898}, "location": {"width": 831, "top": 774, "height": 29, "left": 153}, "words": "与萘普生(500mg,每日两次)联合给药,导致非布司他Cmx和AUC分别增加28%和40%"}, {"probability": {"variance": 0.000957, "average": 0.986479, "min": 0.835427}, "location": {"width": 657, "top": 812, "height": 27, "left": 151}, "words": "该增加无临床意义。而且,萘普生的Cmax或AUC均无显著变化(2%)"}, {"probability": {"variance": 0.000128, "average": 0.995051, "min": 0.941085}, "location": {"width": 810, "top": 848, "height": 30, "left": 191}, "words": "吲哚美辛:本品和吲哚美辛联合给药时,二者都无需进行剂量调整。本品(80mg,每"}, {"probability": {"variance": 0.003734, "average": 0.976148, "min": 0.643173}, "location": {"width": 846, "top": 884, "height": 30, "left": 152}, "words": "日一次)和吲哚美辛(50mg,每日两次)联合给药,非布司他或吲哚美辛的Cmax或AUC未产"}, {"probability": {"variance": 5.7e-05, "average": 0.993807, "min": 0.97446}, "location": {"width": 209, "top": 924, "height": 26, "left": 150}, "words": "生任何显著变化(<7%)"}, {"probability": {"variance": 0.000101, "average": 0.993985, "min": 0.954453}, "location": {"width": 809, "top": 961, "height": 28, "left": 191}, "words": "氢氯噻嗪:本品与氢氯噻嗪联合给药时,无需进行剂量调整。本品(80mg)与氢氯噻嗪"}, {"probability": {"variance": 0.012187, "average": 0.964605, "min": 0.358714}, "location": {"width": 847, "top": 997, "height": 29, "left": 153}, "words": "50mg)联合给药,非布司他的CmaxAUC未产生任何有临床意义的变化(<4%),而且血清"}, {"probability": {"variance": 1.5e-05, "average": 0.997415, "min": 0.98742}, "location": {"width": 219, "top": 1034, "height": 27, "left": 149}, "words": "尿酸浓度未受显著影响"}, {"probability": {"variance": 7.1e-05, "average": 0.994407, "min": 0.966546}, "location": {"width": 808, "top": 1072, "height": 28, "left": 193}, "words": "华法林:华法林与本品联合给药无需进行剂量调整。本品(80mg,每日一次)与华法林"}, {"probability": {"variance": 0.000478, "average": 0.993806, "min": 0.864691}, "location": {"width": 855, "top": 1108, "height": 28, "left": 149}, "words": "联合给药,对健康受试者华法林药代动力学无影响。本品给药也未对国际标准化比值"}, {"probability": {"variance": 0.001084, "average": 0.987758, "min": 0.865334}, "location": {"width": 349, "top": 1144, "height": 27, "left": 161}, "words": "(NR)和凝血因子活性产生影响"}, {"probability": {"variance": 0.000664, "average": 0.989163, "min": 0.843415}, "location": {"width": 809, "top": 1182, "height": 29, "left": 191}, "words": "地昔帕明:CYP2D6底物(如地昔帕明)与本品联合给药,无需进行剂量调整。体外和体"}, {"probability": {"variance": 0.000788, "average": 0.988219, "min": 0.82095}, "location": {"width": 852, "top": 1218, "height": 31, "left": 150}, "words": "内试验表明非布他是CYP2D6的弱抑制剂。非布司他(120mg,每日一次)与地昔帕明"}, {"probability": {"variance": 0.004299, "average": 0.969065, "min": 0.615541}, "location": {"width": 848, "top": 1258, "height": 29, "left": 152}, "words": "(5mg)联合给药导致地昔帕明的Cmax(16%)和AUC(22%)增加,这与2羟基地昔帕明与地昔"}, {"probability": {"variance": 0.008546, "average": 0.976163, "min": 0.563535}, "location": {"width": 397, "top": 1297, "height": 26, "left": 150}, "words": "帕明的代谢比率下降17%有关(根据AUC)"}, {"probability": {"variance": 1e-06, "average": 0.998934, "min": 0.997798}, "location": {"width": 75, "top": 1334, "height": 26, "left": 146}, "words": "【贮藏】"}, {"probability": {"variance": 5e-06, "average": 0.998133, "min": 0.991224}, "location": {"width": 291, "top": 1370, "height": 27, "left": 191}, "words": "遮光,密封,不超过25℃保存"}, {"probability": {"variance": 0, "average": 0.999759, "min": 0.99963}, "location": {"width": 75, "top": 1409, "height": 26, "left": 145}, "words": "【包装】"}, {"probability": {"variance": 0.000638, "average": 0.989378, "min": 0.896185}, "location": {"width": 277, "top": 1445, "height": 28, "left": 192}, "words": "铝塑包装,10片/板,1板/盒"}, {"probability": {"variance": 6.1e-05, "average": 0.994098, "min": 0.979733}, "location": {"width": 97, "top": 1484, "height": 27, "left": 145}, "words": "【有效期】"}, {"probability": {"variance": 1.8e-05, "average": 0.997037, "min": 0.989804}, "location": {"width": 71, "top": 1522, "height": 26, "left": 192}, "words": "24个月"}, {"probability": {"variance": 1e-05, "average": 0.997287, "min": 0.992759}, "location": {"width": 117, "top": 1560, "height": 26, "left": 146}, "words": "【执行标准】"}], "language": 3}